Why Is FMC CORP (FMC) Stock Down Today?

FMC shares fell 34.55% to $5.30, driven by a significant reduction in third-quarter guidance. The company cited weaker-than-expected demand and price cuts on certain products as primary factors.

What Happened

FMC updated its third-quarter 2026 outlook, projecting revenue of $65 million to $125 million and adjusted EBITDA of negative $565 million to negative $510 million. The company stated that revised expectations include an estimated commercial reset of $625 million to $75 million to address channel inventory friction. An 8-K filed on October 15, 2026, disclosed the preliminary results and financial statements.

Following the announcement, RBC Capital lowered its price target to $9 from $11. Mizuho maintained an Outperform rating but lowered its price target to $12. UBS maintained a Neutral rating and lowered its price target to $10.

What The Data Shows

The stock opened at $8.07, hit a session high of $8.10 at 7:30 AM ET, and reached a session low of $4.28 at 8:10 AM ET. Volume so far stands at 3.9 million shares, which is 0.9 times the three-month daily average. FMC has a market cap of $1.3 billion and is unprofitable, with trailing twelve-month EPS of negative $21.50. Revenue declined 21.3% over the trailing twelve months, and net margin stands at negative 84.8%. The 52-week range is $8.04 to $31.30.

In the last 8 sessions, the stock moved down 10.1% from $9.00 to $8.09. On October 14, 2026, the stock printed 3 fresh 52-week highs and 20 fresh 52-week lows. A dividend of $0.08 per share was effective on September 30, 2026.

What To Watch

Investors will monitor coverage breadth and subsequent analyst reactions to the revised guidance. The company has also announced the submission of a regulatory dossier for Rimisoxafen to Brazilian regulatory authorities.